Artificial intelligence technologies are demonstrating significant breakthroughs in oncology, ranging from automated segmentation and prediction of metastatic spread using imaging, to the development of AI-assisted diagnostic tools that outperform traditional biomarkers. Multiple research projects have introduced novel AI models for radiological analysis in cancers such as pancreatic, lung, and oropharyngeal carcinomas, improving diagnostic accuracy and treatment planning. These advancements promise to enhance clinical decision-making and enable more personalized cancer care.